4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-23-002201
CEO and President sold 91,868 shares at $0.88 ($80,614)
From the SEC's structured data for this filing
Trades in this filing
Butler John P. · CEO and President
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-01 | Sale : show line 1 in the form | −38,259 | $0.88 | $33,572 | 1,622,481 | D |
| 2023-03-01 | Sale : show line 2 in the form | −47,239 | $0.88 | $41,452 | 1,575,242 | D |
| 2023-03-01 | Sale : show line 3 in the form | −6,370 | $0.88 | $5,590 | 1,568,872 | D |
| Open-market sales · 91,868 sh · avg $0.88 · $80,614 | ||||||
Loading xslF345X03/primarydocument.xml…